LBF20207PG31: Difference between revisions
m (LBF20307PG15 moved to LBF20207PG31) |
No edit summary |
||
Line 5: | Line 5: | ||
|LipidMaps=LMFA03010036 | |LipidMaps=LMFA03010036 | ||
|SysName=9alpha,11beta,15S-trihydroxy-prosta-5Z,13E-dien-1-oic acid | |SysName=9alpha,11beta,15S-trihydroxy-prosta-5Z,13E-dien-1-oic acid | ||
|Common Name=&&11beta-Prostaglandin | |Common Name=&&11beta-Prostaglandin F_2alpha&& | ||
}} | }} |
Revision as of 07:30, 19 December 2008
IDs and Links | |
---|---|
LipidBank | XPR1719 |
LipidMaps | LMFA03010036 |
CAS | |
KEGG | {{{KEGG}}} |
KNApSAcK | {{{KNApSAcK}}} |
mol | LBF20207PG31 |
11β-Prostaglandin F_2α | |
---|---|
Structural Information | |
9α,11β,15S-trihydroxy-prosta-5Z,13E-dien-1-oic acid | |
| |
Formula | C20H34O5 |
Exact Mass | 354.240624198 |
Average Mass | 354.48096000000004 |
SMILES | C(CC[C@@H](O)C=C[C@H]([C@H]1CC=CCCCC(O)=O)[C@H](C[C@@H]1O)O)CC |
Physicochemical Information | |
Spectral Information | |
Mass Spectra | |
UV Spectra | |
IR Spectra | |
NMR Spectra | |
Other Spectra | |
Chromatograms |
Reported Metabolites, References | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
|